Cited by 728Dermatology and Skin DiseasesContact Dermatitis and AllergiesHealth Systems, Economic Evaluations, Quality of Life

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

The burden of atopic dermatitis: summary of a report for the National Eczema Association.

Open access

Drucker, Aaron M., Wang, Annie R., Li, Wen-Qing, Sevetson, Erika, Block, Julie K., Qureshi, Abrar A.·2017·Journal of Investigative Dermatology

DOI 10.1016/j.jid.2016.07.012

Open this paper in CoChat — free account Open PDF

Abstract

To assess the patient-level and societal burden of atopic dermatitis, we comprehensively reviewed the literature related to quality of life, social, economic, academic, and occupational impacts. Atopic dermatitis has profound impacts on patient and family quality of life. A conservative estimate of the annual costs of atopic dermatitis in the United States is $5.297 billion (in 2015 USD). People with atopic dermatitis may change their occupation because of their skin disease. Research gaps include quality of life assessments outside of tertiary care centers, impacts on partners and families of adult patients, and updated comprehensive cost estimates.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.jid.2016.07.012

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Untitled work
Bickers (2006) · doi:10.1016/j.jaad.2006.05.048 · Cited by 741
Eczema Prevalence in the United States: Data from the 2003 National Survey of Children's Health
Shaw, T., Currie, G. P., Koudelka, C. W., & Simpson, E. L. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.251 · Cited by 721
A comparative study of impairment of quality of life in children with skin disease and children with other chronic childhood diseases: QoL impairment in children with skin disease vs. other diseases
Beattie, P. E., & Lewis-Jones, M. S. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2006.07185.x · Cited by 526
Sleep Disturbances in Adults with Eczema Are Associated with Impaired Overall Health: A US Population-Based Study
Silverberg, J. I., Garg, N. K., Paller, A. S., Fishbein, A. B., & Zee, P. C. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.325 · Cited by 346
Patient perspectives on the management of atopic dermatitis
Zuberbier, T., Orlow, S. J., Paller, A. S., Taı̈eb, A., Allen, R., Hermosa, J. M. H., Ocampo‐Candiani, J., Cox, M., Langeraar, J., & Simon, J. C. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.02.031 · Cited by 343
Effects of Atopic Dermatitis on Young American Children and Their Families
Chamlin, S. L., Frieden, I. J., Williams, M. L. K., & Chren, M. (2004) · PEDIATRICS · doi:10.1542/peds.2004-0374 · Cited by 316
Atopic dermatitis is associated with a decrement in health‐related quality of life
Kiebert, G. M., Sorensen, S. V., Revicki, D. A., Fagan, S. C., Doyle, J. J., Cohen, J. L., & Fivenson, D. P. (2002) · International Journal of Dermatology · doi:10.1046/j.1365-4362.2002.01436.x · Cited by 287
Persistence of Mild to Moderate Atopic Dermatitis
Margolis, J. S., Abuabara, K., Bilker, W. B., Hoffstad, O., & Margolis, D. J. (2014) · JAMA Dermatology · doi:10.1001/jamadermatol.2013.10271 · Cited by 277
Life quality assessment among patients with atopic eczema
Holm, E., Wulf, H. C., Stegmann, H., & Jemec, G. B. E. (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.07050.x · Cited by 227
Relationship between itch and psychological status of patients with atopic dermatitis
Chrostowska‐Plak, D., Reich, A., & Szepietowski, J. C. (2012) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2012.04578.x · Cited by 210

Show all 42 references

Sorted by citations

Atopic dermatitis
Langan, S., Irvine, A. D., & Weidinger, S. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31286-1 · Cited by 1,996
Atopic dermatitis
Weidinger, S., Beck, L. A., Bieber, T., Kabashima, K., & Irvine, A. D. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0001-z · Cited by 1,549
Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis
Guttman‐Yassky, E., Bissonnette, R., Ungar, B., Suárez‐Fariñas, M., Ardeleanu, M., Esaki, H., Suprun, M., Estrada, Y. D., Xu, H., Peng, X., et al. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.08.022 · Cited by 715
The global burden of atopic dermatitis: lessons from the Global Burden of Disease Study 1990–2017*
Laughter, M. R., Maymone, M. B. C., Mashayekhi, S., Arents, B. W. M., Karimkhani, C., Langan, S., Dellavalle, R. P., & Flohr, C. (2020) · British Journal of Dermatology · doi:10.1111/bjd.19580 · Cited by 658
Molecular Mechanisms of Atopic Dermatitis Pathogenesis
Sroka-Tomaszewska, J., & Trzeciak, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084130 · Cited by 605
Commonality of the IL-4/IL-13 pathway in atopic diseases
Gandhi, N. A., Pirozzi, G., & Graham, N. M. H. (2017) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2017.1298443 · Cited by 493
Atopic Dermatitis in America Study: A Cross-Sectional Study Examining the Prevalence and Disease Burden of Atopic Dermatitis in the US Adult Population
Fuxench, Z. C. C., Block, J. K., Boguniewicz, M., Boyle, J. M., Fonacier, L. S., Gelfand, J. M., Grayson, M. H., Margolis, D. J., Mitchell, L., Silverberg, J. I., et al. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.08.028 · Cited by 420
Self-citation
Burden and socioeconomics of asthma, allergic rhinitis, atopic dermatitis and food allergy
Dierick, B. J. H., van der Molen, T., Blok, B. M. J. F.-D., Muraro, A. M., Postma, M. J., Kocks, J. W. H., & van Boven, J. F. M. (2020) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2020.1819793 · Cited by 385
Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis
Silverberg, J. I., Guttman‐Yassky, E., Thaçi, D., Irvine, A. D., Gold, L. S., Blauvelt, A., Simpson, E. L., Chu, C., Liu, Z., Lima, R. G., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2206714 · Cited by 363
Atopic dermatitis
Guttman‐Yassky, E., Renert‐Yuval, Y., & Brunner, P. M. (2025) · The Lancet · doi:10.1016/s0140-6736(24)02519-4 · Cited by 357
Efficacy and Safety of Lebrikizumab, a High-Affinity Interleukin 13 Inhibitor, in Adults With Moderate to Severe Atopic Dermatitis: A Phase 2b Randomized Clinical Trial
Guttman-Yassky, E., Blauvelt, A., Eichenfield, L. F., Paller, A. S., Armstrong, A. W., Drew, J., Gopalan, R., & Simpson, E. L. (2020) · JAMA Dermatology · doi:10.1001/jamadermatol.2020.0079 · Cited by 341
Artificial Intelligence in Dermatology Image Analysis: Current Developments and Future Trends
Li, Z., Koban, K. C., Schenck, T. L., Giunta, R. E., Li, Q., & Sun, Y. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11226826 · Cited by 291
Update on the Pathogenesis and Therapy of Atopic Dermatitis
Li, H., Zhang, Z., Zhang, H., Guo, Y., & Yao, Z. (2021) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-021-08880-3 · Cited by 277
When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council
Simpson, E. L., de Bruin-Weller, M. S., Flohr, C., Ardern‐Jones, M. R., Barbarot, S., Deleuran, M. S., Bieber, T. R. M., Vestergaard, C., Brown, S., Cork, M. J., et al. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2017.06.042 · Cited by 241
Self-citation
Epidemiology of adult atopic dermatitis
Sacotte, R. M., & Silverberg, J. I. (2018) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2018.05.007 · Cited by 235
Skin emollient and early complementary feeding to prevent infant atopic dermatitis (PreventADALL): a factorial, multicentre, cluster-randomised trial
Skjerven, H. O., Rehbinder, E. M., Vettukattil, R., LeBlanc, M., Granum, B., Haugen, G., Hedlin, G., Landrø, L., Marsland, B. J., Rudi, K., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(19)32983-6 · Cited by 234
Treatment of atopic dermatitis with ruxolitinib cream (JAK1/JAK2 inhibitor) or triamcinolone cream
Kim, B. S., Howell, M. D., Sun, K., Papp, K., Nasir, A., & Kuligowski, M. E. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.08.042 · Cited by 226
Gut Microbiota, Probiotics, and Their Interactions in Prevention and Treatment of Atopic Dermatitis: A Review
Fang, Z., Li, L., Zhang, H., Zhao, J., Lu, W., & Chen, W. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.720393 · Cited by 200
Persistence of mature dendritic cells, T H 2A, and Tc2 cells characterize clinically resolved atopic dermatitis under IL-4Rα blockade
Bangert, C., Rindler, K., Krausgruber, T., Alkon, N., Thaler, F. M., Kurz, H., Ayub, T., Demirtas, D., Fortelny, N., Vorstandlechner, V., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abe2749 · Cited by 205
Therapeutic pipeline for atopic dermatitis: End of the drought?
Paller, A. S., Kabashima, K., & Bieber, T. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.07.006 · Cited by 192
Atopic Eczema in Adulthood and Risk of Depression and Anxiety: A Population-Based Cohort Study
Schonmann, Y., Mansfield, K. E., Hayes, J., Abuabara, K., Roberts, A., Smeeth, L. L., & Langan, S. (2019) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2019.08.030 · Cited by 187
Understanding the immune landscape in atopic dermatitis: The era of biologics and emerging therapeutic approaches
Moyle, M., Cevikbas, F., Harden, J. L., & Guttman‐Yassky, E. (2019) · Experimental Dermatology · doi:10.1111/exd.13911 · Cited by 163
American Academy of Dermatology Guidelines: Awareness of comorbidities associated with atopic dermatitis in adults
Davis, D. M. R., Drucker, A. M., Alikhan, A., Bercovitch, L. G., Cohen, D. E., Darr, J. M., Eichenfield, L. F., Frazer-Green, L., Paller, A. S., Silverberg, J. I., et al. (2022) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2022.01.009 · Cited by 163
Self-citation
Atopic eczema: burden of disease and individual suffering – results from a large EU study in adults
Ring, J., Zink, A., Arents, B. W. M., Seitz, I. A., Mensing, U., Schielein, M. C., Wettemann, N., Carlo, G. D., & Fink‐Wagner, A. (2019) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.15634 · Cited by 151
The Role of the Environmental Risk Factors in the Pathogenesis and Clinical Outcome of Atopic Dermatitis
Bonamonte, D., Filoni, A., Vestita, M. G., Romita, P., Foti, C., & Angelini, G. D. (2019) · BioMed Research International · doi:10.1155/2019/2450605 · Cited by 143
Dupilumab: A New Paradigm for the Treatment of Allergic Diseases
Sastre, J., & Davila, I. J. (2018) · Journal of Investigational Allergology and Clinical Immunology · doi:10.18176/jiaci.0254 · Cited by 133
Upadacitinib plus topical corticosteroids in atopic dermatitis: Week 52 AD Up study results
Silverberg, J. I., de Bruin-Weller, M. S., Bieber, T. R. M., Soong, W., Kabashima, K., Costanzo, A., Rosmarin, D. M., Lynde, C. W., Liu, J., Gamelli, A., et al. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2021.07.036 · Cited by 130
Recent Developments and Advances in Atopic Dermatitis: A Focus on Epidemiology, Pathophysiology, and Treatment in the Pediatric Setting
Eichenfield, L. F., Stripling, S., Fung, S., Cha, A., O’Brien, A., & Schachner, L. A. (2022) · Pediatric Drugs · doi:10.1007/s40272-022-00499-x · Cited by 124
Vitamin D Deficiency and Effects of Vitamin D Supplementation on Disease Severity in Patients with Atopic Dermatitis: A Systematic Review and Meta-Analysis in Adults and Children
Hattangdi-Haridas, S. R., Lanham-New, S. A., Wong, W. H. S., Ho, M., & Darling, A. L. (2019) · Nutrients · doi:10.3390/nu11081854 · Cited by 122
Skin care interventions in infants for preventing eczema and food allergy
Kelleher, M. M., Cro, S., Cornelius, V. R., Carlsen, K. C. L., Skjerven, H. O., Rehbinder, E. M., Lowe, A. J., Dissanayake, E., Shimojo, N., Yonezawa, K., et al. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013534.pub2 · Cited by 123
Association of Wildfire Air Pollution and Health Care Use for Atopic Dermatitis and Itch
Fadadu, R. P., Grimes, B., Jewell, N. P., Vargo, J., Young, A. T., Abuabara, K., Balmes, J. R., & Wei, M. L. (2021) · JAMA Dermatology · doi:10.1001/jamadermatol.2021.0179 · Cited by 120
Dual-Site Biomimetic Cu/Zn-MOF for Atopic Dermatitis Catalytic Therapy via Suppressing FcγR-Mediated Phagocytosis
Huang, F., Lu, X., Kuai, L., Ru, Y., Jiang, J., Song, J., Chen, S., Mao, L., Li, Y., Li, B., et al. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.3c11059 · Cited by 114
Blood natural killer cell deficiency reveals an immunotherapy strategy for atopic dermatitis
Mack, M. R., Brestoff, J. R., Berrien-Elliott, M. M., Trier, A. M., Yang, T.-L. B., McCullen, M. V. D., Collins, P. L., Niu, H., Bodet, N. D., Wagner, J. A., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aay1005 · Cited by 109
Mesenchymal Stem Cell Therapy for Inflammatory Skin Diseases: Clinical Potential and Mode of Action
Shin, T., Kim, H., Choi, S. O., & Kang, K. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020244 · Cited by 107
Staphylococcal Biofilms in Atopic Dermatitis
Gonzalez, T., Myers, J. M. B., Herr, A. B., & Hershey, G. K. K. (2017) · Current Allergy and Asthma Reports · doi:10.1007/s11882-017-0750-x · Cited by 109
The socioeconomics of atopic dermatitis
Chung, J., & Simpson, E. L. (2018) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2018.12.017 · Cited by 104
The epidemiology of eczema in children and adults in England: A population‐based study using primary care data
de Lusignan, S., Alexander, H., Broderick, C., Dennis, J., McGovern, A. P., Feeney, C., & Flohr, C. (2020) · Clinical & Experimental Allergy · doi:10.1111/cea.13784 · Cited by 102
The global, regional, and national burden of atopic dermatitis in 195 countries and territories: An ecological study from the Global Burden of Disease Study 2017
Urban, K., Chu, S., Giesey, R. L., Mehrmal, S., Uppal, P., Nedley, N., & Delost, G. R. (2020) · JAAD International · doi:10.1016/j.jdin.2020.10.002 · Cited by 98
Atopic Dermatitis in Adults
Silverberg, J. I. (2019) · Medical Clinics of North America · doi:10.1016/j.mcna.2019.08.009 · Cited by 97
Automatic Skin Disease Diagnosis Using Deep Learning from Clinical Image and Patient Information
Muhaba, K. A., Dese, K., Aga, T. M., Zewdu, F. T., & Simegn, G. L. (2021) · Skin Health and Disease · doi:10.1002/ski2.81 · Cited by 93
Hydroxycinnamic Acids and Derivatives Formulations for Skin Damages and Disorders: A Review
Contardi, M., Lenzuni, M., Fiorentini, F., Summa, M., Bertorelli, R., Suarato, G., & Athanassiou, A. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13070999 · Cited by 91
Adhesion of Staphylococcus aureus to Corneocytes from Atopic Dermatitis Patients Is Controlled by Natural Moisturizing Factor Levels
Feuillie, C., Vitry, P., McAleer, M. A., Kežić, S., Irvine, A. D., Geoghegan, J. A., & Dufrêne, Y. F. (2018) · mBio · doi:10.1128/mbio.01184-18 · Cited by 87
Atopic dermatitis: pathomechanisms and lessons learned from novel systemic therapeutic options
Bieber, T. R. M., Paller, A. S., Kabashima, K., Feely, M. A., Rueda, M. J., Terres, J. A. R., & Wollenberg, A. (2022) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.18225 · Cited by 90
Burden of atopic dermatitis in Japanese adults: Analysis of data from the 2013 National Health and Wellness Survey
Arima, K., Gupta, S., Gadkari, A. S., Hiragun, T., Kono, T., Katayama, I., Demiya, S., & Eckert, L. (2018) · The Journal of Dermatology · doi:10.1111/1346-8138.14218 · Cited by 86
Application of Topical Phosphodiesterase 4 Inhibitors in Mild to Moderate Atopic Dermatitis
Yang, H., Wang, J., Zhang, X., Zhang, Y., Qin, Z.-L., Wang, H., & Luo, X. (2019) · JAMA Dermatology · doi:10.1001/jamadermatol.2019.0008 · Cited by 86
Injury, dysbiosis, and filaggrin deficiency drive skin inflammation through keratinocyte IL-1α release
Archer, N. K., Jo, J.-H., Lee, S. K., Kim, D., Smith, B., Ortines, R. V., Wang, Y., Marchitto, M. C., Ravipati, A., Cai, S. S., et al. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.08.042 · Cited by 82
Atopic Dermatitis in Adults
Zeppa, L., Bellini, V., & Lisi, P. (2011) · Dermatitis · doi:10.2310/6620.2011.10042 · Cited by 82
Quality of Life and Psychological Impact in Patients with Atopic Dermatitis
Talamonti, M., Galluzzo, M., Silvaggio, D., Lombardo, P., Tartaglia, C., & Bianchi, L. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10061298 · Cited by 81
Global, regional and national epidemiology of allergic disorders in children from 1990 to 2019: findings from the Global Burden of Disease study 2019
Lv, J.-J., Kong, X.-M., Zhao, Y., Li, X., Guo, Z.-L., Zhang, Y., & Cheng, Z. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-080612 · Cited by 80
Exploring the skin microbiome in atopic dermatitis pathogenesis and disease modification
Hülpüsch, C., Rohayem, R., Reiger, M., & Traidl‐Hoffmann, C. (2024) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2024.04.029 · Cited by 83
Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Dupilumab in Healthy Adult Subjects
Li, Z., Radin, A. R., Li, M., Hamilton, J. D., Kajiwara, M., Davis, J. D., Takahashi, Y., Hasegawa, S., Ming, J. E., DiCioccio, A. T., et al. (2020) · Clinical Pharmacology in Drug Development · doi:10.1002/cpdd.798 · Cited by 76
Artificial Intelligence in Multiphoton Tomography: Atopic Dermatitis Diagnosis
Guimarães, P., Batista, A., Zieger, M., Kaatz, M., & Koenig, K. (2020) · Scientific Reports · doi:10.1038/s41598-020-64937-x · Cited by 75
Safety of upadacitinib in moderate-to-severe atopic dermatitis: An integrated analysis of phase 3 studies
Guttman‐Yassky, E., Thyssen, J. P., Silverberg, J. I., Papp, K. A., Paller, A. S., Weidinger, S., Hong, H., Hendrickson, B. A., Dilley, D., Tenorio, A. R., et al. (2022) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.09.023 · Cited by 75
Skin care interventions in infants for preventing eczema and food allergy
Kelleher, M. M., Phillips, R., Brown, S., Cro, S., Cornelius, V. R., Carlsen, K. C. L., Skjerven, H. O., Rehbinder, E. M., Lowe, A. J., Dissanayake, E., et al. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013534.pub3 · Cited by 77
Racial and ethnic differences in health care utilization for childhood eczema: An analysis of the 2001-2013 Medical Expenditure Panel Surveys
Fischer, A. H., Shin, D. B., Margolis, D. J., & Takeshita, J. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2017.08.035 · Cited by 74
Mind and skin: Exploring the links between inflammation, sleep disturbance and neurocognitive function in patients with atopic dermatitis
Cameron, S., Donnelly, A., Broderick, C., Arichi, T., Bartsch, U., Dazzan, P., Elberling, J., Godfrey, E. L., Gringras, P., Heathcote, L. C., et al. (2023) · Allergy · doi:10.1111/all.15818 · Cited by 75
Difamilast, a selective phosphodiesterase 4 inhibitor, ointment in paediatric patients with atopic dermatitis: a phase III randomized double-blind, vehicle-controlled trial
Saeki, H., Baba, N., Ito, K., Yokota, D., & Tsubouchi, H. (2021) · British Journal of Dermatology · doi:10.1111/bjd.20655 · Cited by 71
Health Care Resource Utilization and Costs Among Adults with Atopic Dermatitis in the United States: A Claims-Based Analysis
Drucker, A. M., Qureshi, A. A., Amand, C., Villeneuve, S., Gadkari, A. S., Chao, J., Kuznik, A., Bégo-Le-Bagousse, G., & Eckert, L. (2017) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2017.10.024 · Cited by 69
Self-citation
Electrical impedance spectroscopy for the characterization of skin barrier in atopic dermatitis
Rinaldi, A. O., Korsfeldt, A., Ward, S., Burla, D., Dreher, A., Gautschi, M., Stolpe, B., Tan, G., Bersuch, E., Melin, D., et al. (2021) · Allergy · doi:10.1111/all.14842 · Cited by 69
Associations of particulate matter with atopic dermatitis and chronic inflammatory skin diseases in South Korea
Park, T. H., Park, S., Cho, M. K., & Kim, S. (2022) · Clinical and Experimental Dermatology · doi:10.1111/ced.14910 · Cited by 67
Update on the pathogenesis of atopic dermatitis.
Criado, P. R., Miot, H. A., Bueno-Filho, R., Ianhez, M., Criado, R. F. J., & de Castro, C. C. S. (2024) · Anais brasileiros de dermatologia · doi:10.1016/j.abd.2024.06.001 · Cited by 66
Association between atopic dermatitis and autoimmune diseases: a population‐based case–control study*
Ivert, L. U., Wahlgren, C., Lindelöf, B., Dal, H., Bradley, M., & Johansson, E. K. (2020) · British Journal of Dermatology · doi:10.1111/bjd.19624 · Cited by 64
Efficacy and Safety of SHR0302, a Highly Selective Janus Kinase 1 Inhibitor, in Patients with Moderate to Severe Atopic Dermatitis: A Phase II Randomized Clinical Trial
Zhao, Y. P., Zhang, L., Ding, Y., Tao, X., Ji, C., Dong, X., Lu, J., Wu, L., Wang, R., Lu, Q., et al. (2021) · American Journal of Clinical Dermatology · doi:10.1007/s40257-021-00627-2 · Cited by 64
Immunopathogenesis of Atopic Dermatitis: Focus on Interleukins as Disease Drivers and Therapeutic Targets for Novel Treatments
Makowska, K., Nowaczyk, J., Blicharz, L., Waśkiel-Burnat, A., Czuwara, J., Olszewska, M., & Rudnicka, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24010781 · Cited by 63
Endotypes of atopic dermatitis
Fyhrquist, N., Yang, Y., Karisola, P., & Alenius, H. T. (2025) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2025.02.029 · Cited by 65
Comorbidities of Atopic Dermatitis: Beyond Rhinitis and Asthma
Andersen, Y. M. F., Egeberg, A., Skov, L., & Thyssen, J. P. (2017) · Current Dermatology Reports · doi:10.1007/s13671-017-0168-7 · Cited by 62
Pruritus in Autoimmune and Inflammatory Dermatoses
Zeidler, C., Pereira, M. P., Huet, F., Misery, L., Steinbrink, K., & Ständer, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01303 · Cited by 62
Financial Burden of Atopic Dermatitis Out-of-Pocket Health Care Expenses in the United States
Begolka, W. S., Chovatiya, R., Thibau, I. J., & Silverberg, J. I. (2020) · Dermatitis · doi:10.1097/der.0000000000000715 · Cited by 62
Atopic Dermatitis
Waldman, A. R., Ahluwalia, J., Udkoff, J., Borok, J. F., & Eichenfield, L. F. (2018) · Pediatrics in Review · doi:10.1542/pir.2016-0169 · Cited by 62
Genetics in Atopic Dermatitis: Historical Perspective and Future Prospects
Brown, S., Elias, M. S., & Bradley, M. (2020) · Acta Dermato Venereologica · doi:10.2340/00015555-3513 · Cited by 64
Kallikrein 7 Promotes Atopic Dermatitis-Associated Itch Independently of Skin Inflammation
Guo, C., Mack, M. R., Oetjen, L. K., Trier, A. M., Pavel, A. B., Guttman‐Yassky, E., Kim, B., & Liu, Q. (2019) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2019.10.022 · Cited by 60
Interleukins 4 and 13 drive lipid abnormalities in skin cells through regulation of sex steroid hormone synthesis
Zhang, C., Chinnappan, M., Prestwood, C. A., Edwards, M., Artami, M., Thompson, B. M., Eckert, K. M., do Vale, G. D., Zouboulis, C. C., McDonald, J. G., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2100749118 · Cited by 59
A phase 3 randomized, multicenter, double-blind study to evaluate the safety of upadacitinib in combination with topical corticosteroids in adolescent and adult patients with moderate-to-severe atopic dermatitis in Japan (Rising Up): An interim 24-week analysis
Katoh, N., Ohya, Y., Murota, H., Ikeda, M., Hu, X., Ikeda, K., Liu, J., Sasaki, T., Chu, A. D., Teixeira, H. D., et al. (2021) · JAAD International · doi:10.1016/j.jdin.2021.11.001 · Cited by 59
Cytokines and Epidermal Lipid Abnormalities in Atopic Dermatitis: A Systematic Review
Upadhyay, P. R., Seminario‐Vidal, L., Abe, B. T., Ghobadi, C., & Sims, J. T. (2023) · Cells · doi:10.3390/cells12242793 · Cited by 60
Filaggrin Gene Mutations with Special Reference to Atopic Dermatitis
Gupta, J., & Margolis, D. J. (2020) · Current Treatment Options in Allergy · doi:10.1007/s40521-020-00271-x · Cited by 57
Dysbiosis of skin microbiota with increased fungal diversity is associated with severity of disease in atopic dermatitis
Schmid, B., Künstner, A., Fähnrich, A., Bersuch, E., Schmid‐Grendelmeier, P., Busch, H. S., Glatz, M., & Bosshard, P. P. (2022) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.18347 · Cited by 56
Inpatient Financial Burden of Atopic Dermatitis in the United States
Narla, S., Hsu, D. Y., Thyssen, J. P., & Silverberg, J. I. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2017.02.975 · Cited by 55
Immune and Inflammatory Reponses to Staphylococcus aureus Skin Infections
Liu, Q., Mazhar, M., & Miller, L. S. (2018) · Current Dermatology Reports · doi:10.1007/s13671-018-0235-8 · Cited by 58
An update on the prevalence, chronicity, and severity of atopic dermatitis and the associated epidemiological risk factors in the Singapore/Malaysia Chinese young adult population: A detailed description of the Singapore/Malaysia Cross-Sectional Genetics Epidemiology Study (SMCGES) cohort
Lim, J. J., Lim, Y. Y. E., Ng, J. Y., Malipeddi, P., Ng, Y. T., Teo, W. Y., Wong, Q. Y. A., Matta, S. A., Sio, Y. Y., Wong, Y. R., et al. (2022) · World Allergy Organization Journal · doi:10.1016/j.waojou.2022.100722 · Cited by 53
The N-Acylethanolamine Acid Amidase Inhibitor ARN077 Suppresses Inflammation and Pruritus in a Mouse Model of Allergic Dermatitis
Sasso, O., Summa, M., Armirotti, A., Pontis, S., Mei, C. D., & Piomelli, D. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2017.07.853 · Cited by 53
Biologic Therapy for Atopic Dermatitis: Moving Beyond the Practice Parameter and Guidelines
Boguniewicz, M. (2017) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2017.08.031 · Cited by 53
The Challenge of Managing Atopic Dermatitis in the United States.
Feldman, S. R., Cox, L., Strowd, L. C., Gerber, R. A., Faulkner, S., Sierka, D., Smith, T. W., Cappelleri, J. C., & Levenberg, M. (2019) · PubMed Central · Cited by 53
Measuring atopic eczema symptoms in clinical practice: The first consensus statement from the Harmonising Outcome Measures for Eczema in clinical practice initiative
Leshem, Y. A., Chalmers, J. R., Apfelbacher, C., Furue, M., Gerbens, L. A. A., Prinsen, C. A. C., Schmitt, J. M., Spuls, P. I., Thomas, K. S., Williams, H. C., et al. (2020) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2019.12.055 · Cited by 53
Economic Burden of Chronic Hand Eczema: A Review
Armstrong, A. W., Hahn-Pedersen, J. H., Bartlett, C., Glanville, J., & Thyssen, J. P. (2022) · American Journal of Clinical Dermatology · doi:10.1007/s40257-021-00669-6 · Cited by 52
Global, regional, and national epidemiology of allergic diseases in children from 1990 to 2021: findings from the Global Burden of Disease Study 2021
Zheng, J., Jin, Y.-J., Wang, C., Feng, C., Lai, X.-Y., Hua, S.-Q., & Tai, J.-H. (2025) · BMC Pulmonary Medicine · doi:10.1186/s12890-025-03518-y · Cited by 52
The Impact of Acne, Atopic Dermatitis, Skin Toxicities and Scars on Quality of Life and the Importance of a Holistic Treatment Approach
Dréno, B., Amici, J. M., Demessant‐Flavigny, A., Wright, C., TAIEB, C., Desai, S. R., & Alexis, A. F. (2021) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s315846 · Cited by 51
The efficacy and safety of IL-13 inhibitors in atopic dermatitis: A systematic review and meta-analysis
Zhang, Y., Jing, D., Cheng, J., Chen, X., Shen, M., & Liu, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.923362 · Cited by 51
Racial/Ethnic Variation in Use of Ambulatory and Emergency Care for Atopic Dermatitis among US Children
Wan, J., Oganisian, A., Spieker, A. J., Hoffstad, O., Mitra, N., Margolis, D. J., & Takeshita, J. (2019) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2019.02.024 · Cited by 51
Mental health impairment among children with atopic dermatitis: A United States population-based cross-sectional study of the 2013-2017 National Health Interview Survey
Wan, J., Takeshita, J., Shin, D. B., & Gelfand, J. M. (2019) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2019.10.019 · Cited by 50
Selective IL-13 inhibitors for the treatment of atopic dermatitis
Gonçalves, F., Freitas, E., & Torres, T. R. (2021) · Drugs in Context · doi:10.7573/dic.2021-1-7 · Cited by 49
Emerging Role of Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis
Singh, R., Heron, C. E., Ghamrawi, R. I., Strowd, L. C., & Feldman, S. R. (2020) · ImmunoTargets and Therapy · doi:10.2147/itt.s229667 · Cited by 49
Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2)
Silverberg, J. I., Gooderham, M., Paller, A. S., Deleuran, M. S., Bunick, C. G., Gold, L. S., Hijnen, D., Calimlim, B., Lee, W., Teixeira, H. D., et al. (2024) · American Journal of Clinical Dermatology · doi:10.1007/s40257-024-00853-4 · Cited by 48
Guidelines for the management of atopic dermatitis (eczema) for pharmacists
Wong, I. T. Y., Tsuyuki, R. T., Cresswell-Melville, A., Doiron, P., & Drucker, A. M. (2017) · Canadian Pharmacists Journal / Revue des Pharmaciens du Canada · doi:10.1177/1715163517710958 · Cited by 48
Self-citation
Topical Ectoine Application in Children and Adults to Treat Inflammatory Diseases Associated with an Impaired Skin Barrier: A Systematic Review
Kauth, M., & Трусова, О. В. (2022) · Dermatology and Therapy · doi:10.1007/s13555-021-00676-9 · Cited by 47
Psychological Health Status and Health-related Quality of Life in Adults with Atopic Dermatitis: A Nationwide Cross-sectional Study in South Korea
Lee, S., Lee, S., Lee, S., Lee, B., Lee, S., & Park, Y. G. (2017) · Acta Dermato Venereologica · doi:10.2340/00015555-2797 · Cited by 47
The Multidimensional Burden of Atopic Dermatitis Among Adults
Elsawi, R., Dainty, K. N., Begolka, W. S., Barta, K., Butler, L., Capozza, K., Eftekhari, S., Tullos, K. Z., Wu, W., & Drucker, A. M. (2022) · JAMA Dermatology · doi:10.1001/jamadermatol.2022.1906 · Cited by 46
Self-citation
The Role of the Gut Microbiome and Microbial Dysbiosis in Common Skin Diseases
Ryguła, I., Pikiewicz, W., Grabarek, B. O., Wójcik, M., & Kaminiów, K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25041984 · Cited by 49
Costs and Treatment Patterns Among Patients with Atopic Dermatitis Using Advanced Therapies in the United States: Analysis of a Retrospective Claims Database
Eichenfield, L. F., DiBonaventura, M., Xenakis, J. J., Lafeuille, M., Duh, M. S., Fakih, I., Levenberg, M., Cappelleri, J. C., & Sikirica, V. (2020) · Dermatology and Therapy · doi:10.1007/s13555-020-00413-8 · Cited by 46
Automatic SCOring of Atopic Dermatitis Using Deep Learning: A Pilot Study
Medela, A., Carthy, T. M., Aguilar, A., Chiesa-Estomba, C. M., & Grimalt, R. (2022) · JID Innovations · doi:10.1016/j.xjidi.2022.100107 · Cited by 45
Patient‐reported outcomes from the JADE COMPARE randomized phase 3 study of abrocitinib in adults with moderate‐to‐severe atopic dermatitis
Thyssen, J. P., Yosipovitch, G., Paul, C. F., Kwatra, S. G., Chu, C., DiBonaventura, M., Feeney, C., Zhang, F., Myers, D. E., Rojo, R., et al. (2021) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.17813 · Cited by 44

Authors: Drucker, A. M., Wang, A. R., Li, W.-Q., Sevetson, E., Block, J. K., & Qureshi, A. A.
Affiliations: Brown University (US)
National Eczema Association (US)
Corresponding author: Drucker, Aaron M.
ORCID: Drucker, Aaron M.
Wang, Annie R.
Sevetson, Erika
Qureshi, Abrar A.
Venue: Journal of Investigative Dermatology
Publisher: Elsevier BV
Published: 2017-01
Volume: 137
Issue: 1
Pages: 26-30
ISSN: 0022-202X (ISSN-L)
DOI: 10.1016/j.jid.2016.07.012
OpenAlex: W2520198258
Cited by: 720
References: 42
Citations by year: 2026: 63 · 2025: 64 · 2024: 110 · 2023: 94 · 2022: 92 · 2021: 99 · 2020: 80 · 2019: 49 · 2018: 30 · 2017: 36
FWCI: 5.49
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 365 d)
Locations: Journal of Investigative Dermatology (publishedVersion)
PubMed (publishedVersion)
Funders: National Eczema Association
Topics: Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
Health Sciences › Medicine › Dermatology › Contact Dermatitis and Allergies
Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
Keywords: atopic dermatitis, disease burden, quality of life, economic burden, health care costs, occupational impact, research impact, social impact, family impact, patient-reported outcomes
MeSH terms: Adult, Child, Chronic Disease, Dermatitis, Atopic, Eczema, Female, Humans, Male, Quality of Life, Societies, Medical, United States, Health Care Costs, Cost of Illness, Sickness Impact Profile

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The burden of atopic dermatitis: summary of a report for the National Eczema Association.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks